Article Details

Athersys (NASDAQ:ATHX) Stock Rating Lowered by Zacks Investment Research

Retrieved on: 2021-01-27 22:30:00

Tags for this article:

Click the tags to see associated articles and topics

Athersys (NASDAQ:ATHX) Stock Rating Lowered by Zacks Investment Research. View article details on hiswai:

Excerpt

Vanguard Group Inc. now owns 9,514,678 shares of the biopharmaceutical company's stock valued at $26,261,000 after purchasing an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up